Adrien Chauchet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adrien Chauchet has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Sophie Michallet
Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France
1 shared publication - Bernadette Corront
Department of Hematology, Centre Hospitalier Anneçy, Anneçy, France
1 shared publication - Bertrand Coiffier
Department of Hematology, Hospices Civils de Lyon, Lyon, France
1 shared publication - Catherine Sebban
Department of Hematology, Centre Leon Berard, Lyon, France
1 shared publication - Daciana Antal
Department of Hematology, Centre Hospitalier de Roanne, Roanne, France
1 shared publication - Eric Deconinck
Department of Hematology, Centre Hospitalier universitaire Besançon, Besançon, France
1 shared publication
Latest Publications
- Open Access
- 8 June 2012
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 5 (1) , 27
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
Background: Extranodal nasal-type NK/T-cell lymphoma is a rare and severe disease. Considering the rarity of this lymphoma in Europe, we conducted a multicentric retrospective study on nasal-type NK/T cell lymphoma to determine the optimal induction strategy and identify prognostic factors.Methods: Thirty-six adult patients with nasal-type NK/T-cell lymphoma were recruited and assessed. In total, 80 % of patients were classified as having upper aerodigestive tract NK/T-cell lymphoma (UNKTL) and 20 % extra-upper aerodigestive tract NK/T-cell lymphoma (EUNKTL).Results: For advanced-stage disease, chemotherapy alone (CT) was the primary treatment (84 %vs.10 % for combined CT + radiation therapy (RT), respectively), while for early-stage disease, 50 % of patients received the combination of CT + RT and 50 % CT alone. Five-year overall survival (OS) and progression-free survival (PFS) rates were 39 % and 33 %. Complete remission (CR) rates were significantly higher when using CT + RT (90 %)versusCT alone (33 %) (p < 0.0001). For early-stage disease, CR rates were 37 % for CT aloneversus100 % for CT + RT. Quality of response was significantly associated with survival, with 5-year OS being 80 % for CR patientsversus0 % for progressive disease patients (p < 0.01).Conclusion: Early RT concomitantly or sequentially with CT led to improved patient outcomes, with quality of initial response being the most important prognosticator for 5-year OS.
- 8 June 2012
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 5 (1) , 27
Open AccessComplete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
Background: Extranodal nasal-type NK/T-cell lymphoma is a rare and severe disease. Considering the rarity of this lymphoma in Europe, we conducted a multicentric retrospective study on nasal-type NK/T cell lymphoma to determine the optimal induction strategy and identify prognostic factors.Methods: Thirty-six adult patients with nasal-type NK/T-cell lymphoma were recruited and assessed. In total, 80 % of patients were classified as having upper aerodigestive tract NK/T-cell lymphoma (UNKTL) and 20 % extra-upper aerodigestive tract NK/T-cell lymphoma (EUNKTL).Results: For advanced-stage disease, chemotherapy alone (CT) was the primary treatment (84 %vs.10 % for combined CT + radiation therapy (RT), respectively), while for early-stage disease, 50 % of patients received the combination of CT + RT and 50 % CT alone. Five-year overall survival (OS) and progression-free survival (PFS) rates were 39 % and 33 %. Complete remission (CR) rates were significantly higher when using CT + RT (90 %)versusCT alone (33 %) (p < 0.0001). For early-stage disease, CR rates were 37 % for CT aloneversus100 % for CT + RT. Quality of response was significantly associated with survival, with 5-year OS being 80 % for CR patientsversus0 % for progressive disease patients (p < 0.01).Conclusion: Early RT concomitantly or sequentially with CT led to improved patient outcomes, with quality of initial response being the most important prognosticator for 5-year OS.